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Abstract
Background: Accidental intake of mushrooms of the Cortinarius species (deadly webcap) may cause irreversible renal
damage and the need for dialysis or transplantation. The species is found in forests of Northern Europe, Scandinavia
and North America and may be mistaken for other edible mushrooms. The highly selective nephrotoxic compound of
the mushroom is called orellanine. Very little is known about the long-term effects of the nephrotoxin.
Methods: We identified patients who ingested deadly webcap in the period of 1979 to 2012. Informed consent and
medical records were obtained for 28 of the 39 cases that occurred during the 34-year period. A case control group
was also studied based on sex, age and initiation of dialysis or transplantation.
Results: The average age at time of the accidental intake was 40 ± 3 (n = 28) years. 64% of patients were male, and 22
of 28 patients developed acute kidney injury requiring dialysis. Serum creatinine peaked at 1 329 ± 133 μmol/l, and
serum urea was 31 ± 3.5 mmol/l. No signs of acute damage were present in any other organ. The average time of
follow-up was 16.9 ± 2.1 years (1.24–34.3 years, n = 28). 15 patients were transplanted and 3 also had a second graft.
At follow-up, 23 patients were alive, and five had died at ages of 67 ± 5 (range 54–84). The outcome was similar in the
case control group with 6 deaths in 20 patients.
Conclusion: We conclude that the long-term prognosis for patients poisoned by deadly webcap who lost their renal
function is not different compared to other patients in active uremic care.
Background
The mushroom known as the deadly webcap or
Cortinarius rubellus (synonymous with Cortinarius
speciosissimus) is occasionally mistaken for eatable chan-
terelles [1–5], Fig. 1. The habitats are unevenly distrib-
uted in Europe and North America and reports of
poisoning episodes have been made from forestry areas
throughout these regions. One to three of the deadly
webcaps is considered enough to cause severe renal fail-
ure. There are usually no acute symptoms and the pa-
tient will seek medical advice 3 days to a week later with
the symptomatology of uraemia caused by an acute kid-
ney injury. The main symptoms of the uraemia at this
stage are nausea and fatigue. Edema is less common due
to an initial polyuric phase. This is in turn due to the
tubulo-interstitial nephritis caused by damage to the
tubular cells. In case of more severe poisoning, the
patient becomes anuric after around 1 week [4].
The deadly webcap contains a highly selective nephro-
toxin, orellanine, first described by Grzymala [6]. Orella-
nine (or [2, 2′-bipyridine]-3, 3′,4, 4′-tetrol-1, 1′-dioxide)
is present in the mushroom in its basic form as a di-gly-
coside [7, 8]. The mechanism of action is that orellanine
generates oxygen radicals [9–11] and simultaneously
shuts down the oxidative defence, by down-regulating
most anti-oxidative enzymes [9]. In rodents, the highly
kidney-specific nature of orellanine has been verified.
Thus, no acute symptoms have been observed at doses
1–2 orders of magnitude higher than the dose required
to elicit acute renal failure [12, 13].
There are several case reports of the acute intoxication
[1, 2, 14–18]. Due to the lag-phase between intake and
symptoms, there are no signs of toxins in blood [19].
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Suggested therapies during the years have been
hemodialysis, hemoperfusion, corticosteroids and anti-
oxidant therapies with highly varying and inconclusive
results [4, 20, 21]. Regarding long-term effects of the
intoxication, there are only a few reports following
transplantation [17, 22]. There are no long-term follow
up on patients after the initial acute kidney injury phase.
Therefore, we tried to identify all cases of deadly webcap
intoxication during the last three decades in the most af-
fected (South-Western) region of Sweden and compared
their outcome with a case-control group of patients. Our
hypothesis was that the poison might have long-term
effects or increase patient morbidity and mortality.




We included all patients accidentally poisoned by intake
of the mushroom deadly webcap (or Cortinarius rubellus,
also known as Cortinarius speciosissimus) admitted to any
of the hospitals in the Western part of Sweden during the
period of January 1979 to December 2012. The total num-
ber of patients was 39. In this report, 28 patients were
included based on informed consent and available medical
records, see Table 1 for demographic data.
Case control population
For each patient included in the study population that
developed CKD5 (chronic kidney disease stage 5), we
randomly included another patient as case control from
the dialysis unit and another from the transplantation
centre at Sahlgrenska University Hospital. Patients with
diabetes or other systemic disease were excluded. The
case controls were matched in age, sex, comorbidity and
the year of the initiation of dialysis or transplantation.
Such case control subjects could be found for all study
patients in the dialysis group. However, three case
controls are missing during certain years for the trans-
plantation group due to large age differences. Most of
the case control patients included had interstitial
nephritis (75%), glomerulonephritis, or polycystic kidney
disease, see Table 3 for demographic data.
Kidney morphology
Kidney biopsies were taken using gauge 16 needles, fixed
in buffered paraformaldehyde, embedded in paraffin,
sectioned and stained with standard dyes (haematoxylin-
eosin, trichrome, silver and periodic acid-Schiff ) and
evaluated by a renal pathologist.
Statistical analysis
Results are presented as mean ± SEM (standard error of
the mean). Differences between groups were calculated
using the Gehan-Breslow-Wilcoxon test.
Results
Study population
Of the 39 patients identified, we were able to include 28
patients in the study. This was mainly due to difficulties
to be able to get in contact and obtain an informed
consent form from all patients.
Of the 28 patients, 22 required dialysis initially, and 6
did not, Table 1. After 1 month, 21 patients had CKD5
requiring dialysis or transplantation and 7 patients had
CKD stage 3. Thus, there was a 4.5% chance for a
patient initially requiring dialysis to regain renal function
during the first month after the intoxication (1/22). Of
the 7 patients that were dialysis-free 1 month after the
intoxication, all regained most of their renal function
within the first year reaching CKD stage 1 or 2.
Fig. 1 Specimens of the deadly webcap or Cortinarius rubellus (synonymous with Cortinarius speciosissimus), younger and older mushrooms with
slightly different appearance. Picture by Hans Marklund
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For the total study population of 28 patients, the
average time of follow-up was 16.9 ± 2.1 years (minimum
1.24 and maximum 34.3 years). 23 patients were alive at
the time of follow up, but five had died at ages of 67.0 ±
5.1 years. Over the long observation period, three
patients with end stage renal disease (ESRD) and
hemodialysis died at the age of 70 ± 9 years after 11.9 ±
2.5 years on dialysis.
One patient who never required dialysis died 24 years after
the intoxication at the age of 65. Another patient died
19.1 years after the intoxication and 16 years after a success-
ful kidney transplant at the age of 61. Fourteen patients were
transplanted and of these three had a second kidney graft
12–15 years after the first one. The average age at the time
of the accidental intake of poisonous mushrooms was 40 ±
3 years (n= 28), and 64% of patients were male. In the study
group, 3 of the 16 transplanted patients developed cancer in
the form of lymphoma, oral or skin cancer. Information of
the specific cancer diagnosis was not available for the case
control group.
Acute effects
The serum creatinine of the patients requiring dialysis
peaked at 1 329 ± 133 μmol/l (n = 15) and serum urea
reached 31 ± 3.5 mmol/l (n = 11). The peak creatinine
and urea values were markedly lower in patients that did
not require dialysis, Table 1. Laboratory tests did not
show signs of damage in any other organ apart from the
kidney. Thus, the aspartate amino transferase (ASAT),
alanine amino transferase (ALAT), alkaline phosphatase
(ALP) and bilirubin values were all within their normal
limits in the patients analyzed; 0.35 ± 0,04 μCat/l, 0.34 ±
0.04 μCat/l, 2.38 ± 0.04 μCat/l, and 7.59 ± 0.5 μmol/l
respectively (nALAT = 14, nASAT, ALP, bilirubin = 18).
Patients with non-dialysis dependent kidney injury
Six of the patients that were orellanine intoxicated de-
veloped a less severe kidney injury and never required
dialysis. On average their serum creatinine peaked at
474 ± 117 μmol/l (n = 3) during the first week. Initially,
two patients were treated with three sessions each of
hemoperfusion with charcoal, which in 1979 was sug-
gested as therapy. One patient initially required dialysis
and had a serum creatinine of 1270 μmol/l, but regained
part of her renal function within the first month, and
had a glomerular filtration rate of 87 ml/min 1 year later
determined by 51Cr-EDTA clearance. The 7 patients
who did not develop CKD5 were followed over a time-
period of 18.3 ± 5.8 years, range 1.2–34.3 years.
Patients with dialysis-dependent chronic kidney disease stage 5
One month after the intoxication, 21 of 22 patients still
required dialysis. 14 of them were transplanted, 6
received a kidney graft from a living donor and 8 from a
dead donor. Before transplantation, the patients had
been on dialysis for 19 ± 4 months (range 7–64 months).
Three renal grafts lost their function after 11, 12 and
15 years and a second kidney transplantation was
performed. Those patients now have been living with
their 2nd grafts for 10, 11 and 15 years, Table 1.
Kidney morphology
Kidney biopsies were obtained from 5/28 patients. The
biopsy material from one patient could not be retrieved
and thus material was available from 4 patients. Accord-
ing to clinical data biopsies were obtained 10–21 days
after fungal ingestion. All biopsies showed a similar
pattern dominated by acute tubular necrosis (ATN),
Fig. 2. Two patients (no 5 and 28) showed less severe
damage with focal involvement, while the other two
biopsies (no 20 and 24) showed a diffuse involvement
with generalized inflammation and tubular damage.
These biopsies also showed tubular dilatation, tubular
cellular atrophy and degeneration, Table 2. All biopsies
contained some apoptotic bodies, interstitial edema and
focal inflammation but no eosinophilia. Fibrosis was not
a prominent finding.
Case control population
The case control patients were age and sex matched,
and they started dialysis or were transplanted in the
same year as the patients in the study population,
Table 3. No acceptable case control could be found for
three of the 16 transplanted study patients since the can-
didates were either too old or had systemic disease. The
distribution of kidney disease within the population is
displayed in Table 3. In total, 20 patients were matched,
Fig. 2 Light microscopy from a Cortinarius intoxicated patient
showing proximal tubular damage (arrows) in some tubules. There
are focal apoptotic bodies (arrowheads), denudation and tubular
dilatation (★). Haematoxylin-eosin stain
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7 of the patients were on dialysis and the remaining 13
patients were transplanted, one of them twice. Of the 20
patients, 6 died at a mean age of 67.5 ± 4.7 years after
16.9 ± 6.6 years on dialysis (n= 3, at a mean age of
68 years) and 10.3 ± 2.2 years after transplantation (n= 3,
at a mean age of 66 year), Fig. 3. In the case control
population, one patient died of cancer and three
other patients developed tumours during the observa-
tion period.
Comparisons between study and control populations
Of the 21 patients with ESRD in the study group, 20
were matched; 7 in dialysis and 13 that were trans-
planted. Cancer was not more frequent in the study
group compared to control group. There were 3 cases of
cancer in the study population of 21 patients (14%), of
which all 3 were transplanted. In the control group 3
out of 20 (15%) were diagnosed with cancer, two of
which were transplanted and one which remained in
Table 2 Renal morphology of biopsies from patients with Cortinarius poisoning




5 2v 0 + 0 0 focal minimal minimal minimal
7 – — - - -
20 3v + + + + diffuse severe prominent minimal
24 >10d 0 + + + diffuse prominent slight slight
28 10d 0 + 0 0 focal focal minimal minimal
Table 3 The table describes the demographic data available for the matched control cohortasecond transplant in 2003
A. Matched control patients who had hemodialysis
No#: Born year Transplant 1 Diagnosis Follow up M Follow up Y Death Y CoD Cancer
1 1935 1980 PCK 356 30 2010 Peritonitis Y
2 1925 1986 Amylioidosis 95 8 1994 Unknown Y
3 1965 2002 Crescentic GN 141 12 N
4 1953 2012 IgAN 20 2 N
5 1958 2012 PCK 22 2 N
6 1955 2009 PCK 59 5 N
7 1942 1983 Pyelonephritis 368 31
8 1972 1988a PCK 307 26 N
9 1970 2000 Interstitial Nephritis 156 13
10 1973 2001 IgAN 194 16
11 1952 1992 IgAN 157 13 2005 Epilepsy N
12 1951 1992 Interstitial nephritis 263 22 N
13 1971 1992 CGN 260 22
B. Matched control patients who had a renal transplantation
No#: Born year HD start Diagnosis Follow up M Follow up Y Death Y CoD Cancer
14 1925 1984 CVD 160 13 1997 Cancer Y
15 1916 1984 Heredetary nephropaty 139 12 1996 Sepsis
16 1962 1985 Glomerulonephritis 343 29 Y
17 1942 1987 CVD 72 6 1993 CVD
18 1965 1990 Glomerulonephritis 284 24
19 1952 1999 Glomerulonephritis 178 15
20 1973 2011 Interstitial nephritis 29 2 N
aSecond transplant in 2003, M: months, Y: year, PCK:polycystic kidney disease, Crescentic GN: crescentic glomerulonephritis, IgAN: IgA nephritis, CGN: Chronic
glomerulonephritis, CoD: cause of death, CVD: cardiovascular disease
The cohort was matched based on age, sex and A. initiation of hemodialysis or B. renal transplantation
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dialysis. In total, 4 patients of 21 with ESRD died in the
study group compared to 6 in the control group, see
Fig. 3. There was no statistical difference between sur-
vivals in the study group compared to the case control
group.
Discussion
The present study was done to reveal if patients that ac-
cidentally ingested deadly webcap (Cortinarius rubellus)
suffered from long-term increases in morbidity or mor-
tality. Indeed, 75% of the 28 patients developed CKD5,
and 70% of them were transplanted. However, we did
not find evidence of any other damage apart from the
severe kidney injury. It should be noted that this is still a
small patient group and of 39 cases we were only able to
investigate 28 cases. Possible confounders could be the
limited size of the study or that bias was introduced by
co-morbidities or other medication. However, we do not
anticipate that this has affected the outcome of the
study.
The follow up period after the accidental intake of poi-
sonous webcap is quite long, 16.9 years, with a range of
up to 34.3 years. As expected, the long-term survival
was excellent after transplantation as reflected by the
current follow up period of 19.0 ± 2.5 years for the 14
patients in that group. The result is in accordance with
previous reports over shorter periods of follow up [17,
22]. Regarding dialysis, it is well known that the mortal-
ity is high for all age groups [23]. Naturally, the survival
on dialysis will depend, not only on the dialysis practice,
but also on the underlying disease and on comorbidities
[23–25]. The outcome was quite good for the study
population on dialysis, which so far has been followed
for 12.4 ± 3.4 years. Some patients have died over the
three and a half decades of follow up. However, the pa-
tients on dialysis died after more than 12 years of treat-
ment with haemodialysis at a mean age of 68. A similar
picture was found in the case control population with
follow up periods for transplanted patients of 15.2 ±
2.8 years and of patients on dialysis for 14.4 ± 3.5 years.
In the case control population there were three deaths
in each of the two ESRD groups, with transplanted
patients being 66 years at the time of death, and patients
on dialysis being 68. We found no evidence of increased
risk for malignancy, endocrinological disorders or other
morbidity in the study population.
Conclusion
We conclude that the long-term outcome is equally
good for patients that have lost their renal function due
to accidental intake of deadly webcap compared to other
reasons for the uraemia. This was true both for trans-
planted patients and patients treated with dialysis.
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Fig. 3 Kaplan Mayer survival curve over the two groups. No statistical
differences were seen between the study group (intoxicated patients)
and the control group over time
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